139 related articles for article (PubMed ID: 17929135)
1. Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease.
Morinishi Y; Oh-Ishi T; Kabuki T; Joh K
Mod Rheumatol; 2007; 17(5):413-7. PubMed ID: 17929135
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
Chen L; Hu Y; Yao Y; Zhen XF; Chen F; He Q; Mo X; Ma SC
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):465-9. PubMed ID: 22931947
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi N; Takezaki S; Kobayashi I; Iwata N; Mori M; Nagai K; Nakano N; Miyoshi M; Kinjo N; Murata T; Masunaga K; Umebayashi H; Imagawa T; Agematsu K; Sato S; Kuwana M; Yamada M; Takei S; Yokota S; Koike K; Ariga T
Rheumatology (Oxford); 2015 May; 54(5):784-91. PubMed ID: 25288783
[TBL] [Abstract][Full Text] [Related]
4. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
5. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
[TBL] [Abstract][Full Text] [Related]
6. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
7. Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis.
Kobayashi I; Okura Y; Yamada M; Kawamura N; Kuwana M; Ariga T
J Pediatr; 2011 Apr; 158(4):675-7. PubMed ID: 21232756
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.
Kobayashi I; Yamada M; Takahashi Y; Kawamura N; Okano M; Sakiyama Y; Kobayashi K
Rheumatology (Oxford); 2003 Feb; 42(2):371-4. PubMed ID: 12595639
[TBL] [Abstract][Full Text] [Related]
9. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
10. Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity.
Jindal AK; Guleria S; Pilania RK; Bishnoi A; Vinay K; Dogra S; Suri D; Rawat A; Singh S
Rheumatol Int; 2018 Jun; 38(6):1153-1160. PubMed ID: 29721695
[TBL] [Abstract][Full Text] [Related]
11. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
[TBL] [Abstract][Full Text] [Related]
12. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary outcome in juvenile dermatomyositis: a case-control study.
Sanner H; Aaløkken TM; Gran JT; Sjaastad I; Johansen B; Flatø B
Ann Rheum Dis; 2011 Jan; 70(1):86-91. PubMed ID: 20805295
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
[TBL] [Abstract][Full Text] [Related]
15. Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease.
Hu M; Shen C; Zheng F; Zhou Y; Teng L; Zheng R; Hu B; Wang C; Lu M; Xu X
Respir Res; 2023 Nov; 24(1):286. PubMed ID: 37974162
[TBL] [Abstract][Full Text] [Related]
16. Clinical analysis of 50 children with juvenile dermatomyositis.
Kishi T; Miyamae T; Hara R; Nakajima S; Imagawa T; Mori M; Yokota S
Mod Rheumatol; 2013 Mar; 23(2):311-7. PubMed ID: 22526832
[TBL] [Abstract][Full Text] [Related]
17. Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement.
Tosun A; Serdaroğlu G; Aslan MT; Polat M; Akalin T; Tekgul H; Gökben S
Rheumatol Int; 2006 Sep; 26(11):1040-3. PubMed ID: 16721599
[TBL] [Abstract][Full Text] [Related]
18. Correlation between CT Score and KL-6: A Severity Assessing in Juvenile Dermatomyositis Associated Interstitial Lung Disease.
Wang C; Hou J; Lai J; Tao R; Yang Y; Hao W; Yuan X; Yan Y
Can Respir J; 2023; 2023():5607473. PubMed ID: 37020746
[TBL] [Abstract][Full Text] [Related]
19. [Juvenile dermatomyositis].
Tambić-Bukovac L; Malcić I; Prohić A
Reumatizam; 2001; 48(1):27-33. PubMed ID: 12476739
[TBL] [Abstract][Full Text] [Related]
20. [Interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
Bartosiewicz M; Siemion-Szcześniak I; Sobiecka M; Wyrostkiewicz D; Radwan-Röhrenschef P; Lewandowska K; Langfort R; Oniszh K; Franczuk M; Kuś J
Pneumonol Alergol Pol; 2013; 81(6):556-66. PubMed ID: 24142786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
